Clarus Therapeutics Holdings, Inc.
CRXTDelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817944
Clarus Therapeutics Holdings, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Jun 9, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.82M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Clarus Therapeutics Holdings, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +12 vs. Q2 2021
- Shares held
- 2.26M
- +2.26M vs. Q2 2021
- Total value
- $12.1M
- +$12.1M vs. Q2 2021
- New holders
- 12
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRXT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 2 | $5.00K |
| Q2 2022 | 25 | $1.82M |
| Q1 2022 | 13 | $3.73M |
| Q4 2021 | 12 | $10.5M |
| Q3 2021 | 12 | $12.1M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Clarus Therapeutics Holdings, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bracebridge Capital, LLC | 2,002,495 | $10.7M | 3.83% | +2,002,495 | New |
| Telemetry Investments, L.L.C. | 45,000 | $240.0K | 0.33% | +45,000 | New |
| Tower Research Capital LLC (TRC) | 43,345 | $231.0K | 0.01% | +43,345 | New |
| Powell Investment Advisors, LLC | 43,000 | $229.0K | 0.14% | +43,000 | New |
| UBS Group AG | 38,654 | $206.0K | 0.00% | +38,654 | New |
| Verition Fund Management LLC | 30,000 | $160.0K | 0.00% | +30,000 | New |
| Susquehanna International Group, LLP | 22,543 | $120.0K | 0.00% | +22,543 | New |
| Virtu Financial LLC | 17,704 | $94.0K | 0.01% | +17,704 | New |
| Cowen and Company, LLC | 10,000 | $53.0K | 0.00% | +10,000 | New |
| JPMorgan Chase & Co | 7,846 | $42.0K | 0.00% | +7,846 | New |
| Bank of America Corp | 100 | $1.00K | 0.00% | +100 | New |
| Royal Bank of Canada | 200 | $1.00K | 0.00% | +200 | New |